A rating of 77 puts Greenwich Lifesciences Inc (GLSI) near the top of the Biotechnology industry according to InvestorsObserver. Greenwich Lifesciences Inc's score of 77 means it scores higher than 77% of stocks in the industry. Greenwich Lifesciences Inc also received an overall rating of 62, putting it above 62% of all stocks. Biotechnology is ranked 50 out of the 148 industries.
GLSI has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on GLSI!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Greenwich Lifesciences Inc Stock Today?
Greenwich Lifesciences Inc (GLSI) stock is higher by 2.76% while the S&P 500 is down -0.23% as of 2:06 PM on Wednesday, Dec 14. GLSI is up $0.36 from the previous closing price of $13.03 on volume of 19,086 shares. Over the past year the S&P 500 is down -13.46% while GLSI is down -48.87%. GLSI lost -$0.57 per share the over the last 12 months.
Click Here to get the full Stock Report for Greenwich Lifesciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
